• BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
FinanceTime
  • August 20th, 2026

FinanceTimeFinancetime

  • BUSINESS
    • FINANCE
    • LEGAL
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • HEALTHCARE & PHARMACEUTICALS
    • MEDIA & TELECOM
    • AEROSPACE AND DEFENSE
    • ENERGY
  • MARKETS
    • EUROPEAN MARKETS
    • ASIAN MARKETS
    • U.S. MARKETS
    • COMMODITIES
    • EMERGING MARKETS
    • DEALS
    • RATES & BONDS
  • WORLD
    • UNITED STATES
    • EUROPE
    • UNITED KINGDOM
    • ASIA PACIFIC
    • MIDDLE EAST
    • AFRICA
    • CHINA
    • INDIA
    • JAPAN
    • AMERICAS
    • FRANCE
    • GERMANY
  • POLITICS
    • GOVERNMENT
    • UNITED STATES
    • US SUPREME COURT
  • TECH
    • ARTIFICIAL INTELLIGENCE
    • CYBERSECURITY
    • SPACE
    • DISRUPTED
  • COMMENTARY
  • BREAKINGVIEWS
    • BREAKINGVIEWS PREDICTIONS
  • MONEY
    • WEALTH
    • FUNDS
    • ETFS
  • LIFE
    • LIFESTYLE
    • SPORTS
    • SCIENCE
  • SECTORS
    • ENERGY
    • HEALTHCARE
    • MEDIA & TELECOM
    • SUSTAINABILITY
    • ENVIRONMENT
    • RETAIL & CONSUMER
    • AUTOS & TRANSPORTATION
    • AEROSPACE AND DEFENSE
An American flag and USAID flag fly outside the USAID building in Washington, D.C., U.S., February 1, 2025. Annabelle Gordon
An American flag and USAID flag fly outside the USAID building in Washington, D.C., U.S., February 1, 2025. Annabelle Gordon
Home
Business
Healthcare & Pharmaceuticals

Services collapsing as USAID cuts health contracts worldwide

February 27th, 2025 | 12:48 PM BUSINESS Healthcare & Pharmaceuticals 3

Facebook Twitter Google+ LinkedIn Pinterest

Worth reading...

Multistate salmonella infections climb to 431, US CDC says
Ultragenyx's gene therapy wins first FDA approval for rare metabolic disorder
Michigan confirms human case of rare mosquito-borne disease
US FDA approves Regeneron's rare bone disorder drug
By Nellie Peyton, Jennifer Rigby

U.S.-funded health projects around the world, including those providing lifesaving care, received termination notices from Washington on Thursday as President Donald Trump's administration neared completion of a review to ensure grants are aligned with its "America First" policy.

Trump ordered a 90-day pause on all foreign aid in January pending assessments of how projects were consistent with this foreign policy.

U.S. Secretary of State Marco Rubio has dismissed concerns that Washington is ending foreign aid, saying waivers had been provided to life-saving aid.

Only weeks later, the administration decided to terminate more than 90% of the programs globally, according to a February 25 court document, including many that were initially covered by waivers such as work tackling HIV as well as wider health programs.

Several of the largest U.S.-funded HIV/AIDS programmes in South Africa were told that their funding would not resume, according to three senior leaders at health organizations, while a global non-profit that works on malaria and maternal and newborn health had the majority of its contracts cancelled.

UNAIDS, the United Nations agency tackling HIV and AIDS, had its contract with the United States Agency for International Development (USAID) cancelled, documents reviewed by Reuters showed.

Khana in Cambodia, an HIV and TB organisation, also got a termination notice, according to a source familiar with its work.

There was no immediate response to a request for comment from the U.S. State Department.

Reuters was not immediately able to determine how many organisations worldwide were affected, or exactly what the criteria were for termination.

"Secretary Rubio and (USAID) Deputy Administrator (Peter) Marocco have determined your award is not aligned with Agency priorities and made a determination that continuing this program is not in the national interest," said the notice received by organisations, which was seen by Reuters.

International AIDS Society President Beatriz Grinsztejn, referring to cuts worldwide, said: "The U.S. funding cuts are dismantling the system. HIV treatment is crumbling. TB services are collapsing... Lives are on the line." Her organisation is not affected directly.

Some of the programmes that were cut in South Africa provided HIV/AIDS services to vulnerable groups such as LGBT+ people and sex workers.

Others provided HIV testing and services to the general population, said Francois Venter, executive director of the Ezintsha Research Centre in Johannesburg, which is not funded by USAID.

South Africa has the world's largest number of people living with HIV, at around 8 million.

"The programmes who received their termination letters this morning were among the most efficient, effective health delivery programmes in the country," said Venter, calling it a "devastating blow" for South Africa's HIV response.

  • Topic
  • USA
  • HEALTH (PIX)
  • TRUMP/AID
Facebook Twitter Google+ LinkedIn Pinterest
Previous article Multistate salmonella infections climb to 431, US CDC says

Related Posts

Healthcare & Pharmaceuticals
August 19th, 2026

Multistate salmonella infections climb to 431, US CDC says

Healthcare & Pharmaceuticals
August 19th, 2026

Ultragenyx's gene therapy wins first FDA approval for rare metabolic dis...

Healthcare & Pharmaceuticals
August 19th, 2026

Michigan confirms human case of rare mosquito-borne disease

Healthcare & Pharmaceuticals
August 19th, 2026

US FDA approves Regeneron's rare bone disorder drug

Healthcare & Pharmaceuticals
August 19th, 2026

West Nile virus outbreak kills four in North Macedonia 

Healthcare & Pharmaceuticals
August 19th, 2026

Moderna shares double as cancer vaccine data rekindles investor hopes

The Wire
Aug 20th 4 h ago
Investigates

In China, rocket launches fuel tourism and space-age dreams

Aug 19th 4 h ago
Asia Pacific

Japan exports rise 23.2% year/year in July

Aug 19th 4 h ago
Baseball

D-backs score twice in 10th, salvage series finale at Red S...

Aug 19th 5 h ago
Government

US tells schools not to alter discipline policies to reduce...

Aug 19th 5 h ago
Transactional

China tax crackdown forces wealthy investors to assess thei...

TRENDING ON FINANCETIME
Aug 19th, 2026 Tennis

Paul ousts top seed Zverev to reach Cincinnati quarter-finals

Aug 19th, 2026 Litigation

AIA Group's first-half new business value rises 10%

Aug 19th, 2026 Energy

Brazil's largest thermal power plant shut down after equipment failure

Aug 19th, 2026 United Kingdom

Key moments in Prince Harry and Meghan's six years in California

Aug 19th, 2026 Sports

Orioles reinstate C Samuel Basallo (shoulder) to active roster

Markets-Sectors
ENERGY -0.16%
FINANCIALS -0.62%

  • BUSINESS
  • MARKETS
  • WORLD
  • POLITICS
  • TECH
  • COMMENTARY
  • BREAKINGVIEWS
  • MONEY
  • LIFE
  • SECTORS
  • Back to top
FinanceTime
FinanceTime

World Business & Financial News, Breaking US & International News

Additional Services
  • Privacy-Policy
  • Terms and Conditions
© Financetime.org 2026. All rights reserved. Hosted by LeadsDeposit.com
Produced by C-iT